SequelSEC

GRAIL, Inc. GRAL

Services-Medical Laboratories · CIK 0001699031 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$147.17M
Fiscal year ended 2025-12-31
Operating income
-$562.16M
Fiscal year ended 2025-12-31
Free cash flow
-$299.92M
Fiscal year ended 2025-12-31

GRAIL, Inc. (GRAL) reported revenue of $147.17M and net income of -$408.35M for the fiscal year ended 2025-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from GRAIL, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

GRAIL, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312023-01-01
Revenue$147.17M$125.60MUnavailable$55.55M
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating income-$562.16M-$2.19BUnavailable-$5.44B
Net income-$408.35M-$2.03BUnavailable-$5.40B
Research & development$195.79M$322.38MUnavailable$329.58M
Weighted-average diluted sharesshares 36.75Mshares 31.90MUnavailableshares 31.05M
Pretax income-$534.50M-$2.16BUnavailable-$5.44B
Income tax expense-$126.15M-$135.36MUnavailable-$42.29M
Diluted EPS$-11.11$-63.54Unavailable$-173.89
Selling, general & administrative$275.80M$367.82MUnavailable$296.44M
General & administrative$159.10M$213.86MUnavailable$174.11M
Selling & marketing$116.69M$153.96MUnavailable$122.33M

Balance

GRAIL, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312023-01-01
Cash & equivalents$249.73M$214.23MUnavailable$241.60M
Total assets$2.92B$2.98BUnavailableUnavailable
Current assets$953.85M$819.86MUnavailableUnavailable
Total liabilities$344.15M$479.90MUnavailableUnavailable
Current liabilities$79.67M$76.92MUnavailableUnavailable
Total equity incl. NCI$2.58B$2.50BUnavailableUnavailable
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivable$18.30M$20.31MUnavailableUnavailable
GoodwillUnavailable$0Unavailable$1.50B
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payable$2.08M$4.84MUnavailableUnavailable

Cash flow

GRAIL, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312023-01-01
Operating cash flow-$299.01M-$577.16MUnavailable-$561.31M
Capital expenditures$909.00K$5.21MUnavailable$22.86M
Investing cash flow-$85.05M-$551.01MUnavailable-$22.86M
Financing cash flow$423.32M$1.24BUnavailable$604.82M
Net change in cash$39.12M$116.07MUnavailable$20.13M
Stock-based compensation$58.28M$86.08MUnavailable$75.73M
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailable

Derived

GRAIL, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312023-01-01
Free cash flow-$299.92M-$582.36MUnavailable-$584.17M
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating margin-382.0%-1743.0%Unavailable-9798.2%
FCF margin-203.8%-463.7%Unavailable-1051.6%
SBC / revenue39.6%68.5%Unavailable136.3%
Current ratio11.97x10.66xUnavailableUnavailable
Revenue YoY growth17.2%UnavailableUnavailableUnavailable
Net margin-277.5%-1613.9%Unavailable-9719.3%
R&D / revenue133.0%256.7%Unavailable593.3%
CapEx / revenue0.6%4.1%Unavailable41.2%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GRAL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CDNA CELC CFOR CSTL DGX

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2023-12-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2023-12-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.